Dang TNT, et al. - Using the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program that captures variables specific to bariatric surgery from 832 centers, researchers sought the prevalence and predictors of Clostridium difficile infection (CDI) among patients undergoing laparoscopic Roux-en-Y gastric bypass (LRYGB) or laparoscopic sleeve gastrectomy (LSG) in 2016 and 2017. Further, they assessed preoperative factors predictive of 30-day CDI. They analyzed a total of 78,222 LRYGB and 222,968 LSG identifying an overall low incidence of CDI. They observed two times higher rates of CDI after LRYGB compared to LSG. Furthermore, significant adverse outcomes post-operatively were noted in correlation with CDI but with no increased risk of mortality.